New Taxonomy Aims to Standardize False Discovery Rate Control in Omics Research to Prevent Misleading Drug Development
Rapid Read

New Taxonomy Aims to Standardize False Discovery Rate Control in Omics Research to Prevent Misleading Drug Development

What's Happening? A new taxonomy published in Nature Biotechnology seeks to standardize the control of false discovery rates (FDR) in omics research, a field critical for drug development and biomarker discovery. This framework addresses the current ambiguity in how FDR is applied, which has led to
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.